RxDoctor Payments Data

Charles Whitlow, MD

Colon & Rectal Surgery · New Orleans, LANPI 1013941368

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (56.1%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 63.8% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2019 at $8,384 and has fallen 95.2% since, to $403 in 2025. Among colon & rectal surgery clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$21,800in general payments, 2019–2025

Across 66 payments — averaging $330.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$14K
  • Medical Device Business Services, Inc.$4K
  • Johnson & Johnson$949
  • Biom'up France SAS$725
  • Biom'up SA$622
  • Davol Inc.$284
  • plus $2K from 12 others
$75,200in research payments, 2019–2025

Across 17 payments — averaging $4423.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Takeda Pharmaceuticals U.S.A., Inc.$52K
  • Janssen Research & Development, LLC$24K

What the payments were for

  • Consulting fees$4,63821%
  • Speaking & faculty fees$12,22556%
  • Food & beverage$4,93823%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boston Scientific17$13,907
Medical Device Business Services, Inc.2$3,788
Johnson & Johnson12$949
Biom'up France SAS7$725
Biom'up SA8$622
Davol Inc.4$284
Pentax Of America, Inc.1$243
Kerecis Limited1$232
AbbVie3$187
Medtronic(2 entities)2$162
Guard Medical Inc.1$139
Gilead1$125
Baxter Healthcare2$116
Prescient Surgical1$114
Vertex1$87
Stryker1$52
Dilon Technologies, Inc.1$35
Covidien LP1$33

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$21,800 in reported general payments places this provider in the 90th percentile of 39 colon & rectal surgery providers in Louisiana.

See all colon & rectal surgery providers in Louisiana

Medicare billing

Part B allowed, 2024
$38,342
Medicare patients
106
Services billed
174

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates45$3,039
Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl39$672
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl33$527

Paid to pharmacies, not to this prescriber.

Other colon & rectal surgery in New Orleans

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →